13F
中

NGNE NEUROGENE INC

2026Q1 · CUSIP 64135M105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
95
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
56
Δ whales
+4
Inst. holding value
$341M
New positions
19
Closed positions
17
Price momentum (1Q)
+61.0%
Put / Call
2/3

Breadth history (34 quarters)

2024Q1: Δ+25 · h=61 2024Q2: Δ+6 · h=67 2024Q3: Δ+20 · h=87 2024Q4: Δ+3 · h=90 2025Q1: Δ-3 · h=87 2025Q2: Δ-3 · h=84 2025Q3: Δ+5 · h=89 2025Q4: Δ+4 · h=93 2026Q1: Δ+2 · h=95 2024Q1: holders=61 2024Q2: holders=67 2024Q3: holders=87 2024Q4: holders=90 2025Q1: holders=87 2025Q2: holders=84 2025Q3: holders=89 2025Q4: holders=93 2026Q1: holders=95 -25 -12.5 +0 +12.5 +25 5477100 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 17% -12.4% -9.0%
2024Q1 Top 11% +7.5% +3.6%

Options Sentiment

Put holders
2
QoQ: +2
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-4.55
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -1.00 2024-06-30: EPS -1.09 2024-09-30: EPS -1.19 2024-12-31: EPS -1.00 2025-03-31: EPS -1.08 2025-06-30: EPS -1.05 2025-09-30: EPS -0.99 2025-12-31: EPS -1.12 2026-03-31: EPS -1.39 -1.53 -0.76 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)